India approves Russian Covid vaccine Sputnik V for emergency use
Amid the second wave of the corona virus and facing the crisis of vaccines covishield and covaxine, India has approved Russian Covid vaccine Sputnik V for emergency use. Based on the expert panel recommendation. and strong immunogenicity data of Russia-made coronavirus vaccine Sputnik V, A, the Subject Expert Committee (SEC) under India’s drug regulator has called for a meeting, reviewed and approved the emergency-use application of the Russian vaccine. According to the reports, the vaccine’s efficacy is found at 91.4% based on the final control point of clinical trials in Russia.